
Angela A. Armstrong
Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2641, 2741, 2654, 2626 |
| Total Applications | 1003 |
| Issued Applications | 675 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11414347
[patent_doc_number] => 09561155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-07
[patent_title] => 'Method of reducing cholesterol levels using a human anti-PCSK9 antibody'
[patent_app_type] => utility
[patent_app_number] => 13/982373
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 70308
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982373 | Method of reducing cholesterol levels using a human anti-PCSK9 antibody | Jan 26, 2012 | Issued |
Array
(
[id] => 9273530
[patent_doc_number] => 08637462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Methods for reducing platelet counts and/or platelet adhesion by administering a GC-B receptor agonist'
[patent_app_type] => utility
[patent_app_number] => 13/360039
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5163
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360039 | Methods for reducing platelet counts and/or platelet adhesion by administering a GC-B receptor agonist | Jan 26, 2012 | Issued |
Array
(
[id] => 8312591
[patent_doc_number] => 20120189612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER WHILE PREVENTING OR REDUCING CARDIOTOXICITY AND/OR CARDIOMYOPATHY'
[patent_app_type] => utility
[patent_app_number] => 13/357668
[patent_app_country] => US
[patent_app_date] => 2012-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10056
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13357668
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/357668 | COMPOSITIONS AND METHODS FOR TREATING CANCER WHILE PREVENTING OR REDUCING CARDIOTOXICITY AND/OR CARDIOMYOPATHY | Jan 24, 2012 | Abandoned |
Array
(
[id] => 8199283
[patent_doc_number] => 20120122786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Use of Polypeptide Micromolecule MLIF in Preparing Medicine for Preventing and Treating Myocardial Ischemia'
[patent_app_type] => utility
[patent_app_number] => 13/355873
[patent_app_country] => US
[patent_app_date] => 2012-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2156
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122786.pdf
[firstpage_image] =>[orig_patent_app_number] => 13355873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/355873 | Method for treating myocardial ischemia | Jan 22, 2012 | Issued |
Array
(
[id] => 9749776
[patent_doc_number] => 08841251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-23
[patent_title] => 'Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors'
[patent_app_type] => utility
[patent_app_number] => 13/346831
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5697
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13346831
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/346831 | Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors | Jan 9, 2012 | Issued |
Array
(
[id] => 8554708
[patent_doc_number] => 08329177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Method of treating hypertrophic cardiomyopathy'
[patent_app_type] => utility
[patent_app_number] => 13/334387
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 8004
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334387
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/334387 | Method of treating hypertrophic cardiomyopathy | Dec 21, 2011 | Issued |
Array
(
[id] => 8358571
[patent_doc_number] => 20120213730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'ALTERATION OF CELL MEMBRANE FOR NEW FUNCTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/316915
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9227
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316915
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/316915 | Alteration of cell membrane for new functions | Dec 11, 2011 | Issued |
Array
(
[id] => 8054039
[patent_doc_number] => 20120076757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/302868
[patent_app_country] => US
[patent_app_date] => 2011-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13633
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076757.pdf
[firstpage_image] =>[orig_patent_app_number] => 13302868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/302868 | COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES | Nov 21, 2011 | Abandoned |
Array
(
[id] => 7791558
[patent_doc_number] => 20120053114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/291731
[patent_app_country] => US
[patent_app_date] => 2011-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10656
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053114.pdf
[firstpage_image] =>[orig_patent_app_number] => 13291731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/291731 | METHOD | Nov 7, 2011 | Abandoned |
Array
(
[id] => 8208936
[patent_doc_number] => 20120128585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level'
[patent_app_type] => utility
[patent_app_number] => 13/286695
[patent_app_country] => US
[patent_app_date] => 2011-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 63015
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128585.pdf
[firstpage_image] =>[orig_patent_app_number] => 13286695
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/286695 | Method of diagnosing the presence of a tumor in a mammal by assessing CDO expression levels | Oct 31, 2011 | Issued |
Array
(
[id] => 8290357
[patent_doc_number] => 20120178689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHODS OF TREATMENT WITH NATRIURETIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/284529
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8313
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13284529
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/284529 | Methods of treatment of heart failure with natriuretic peptides | Oct 27, 2011 | Issued |
Array
(
[id] => 9094880
[patent_doc_number] => 20130274191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR THERAPEUTIC MODULATION OF ALDOSTERONE LEVELS IN HEART DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/877955
[patent_app_country] => US
[patent_app_date] => 2011-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10448
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877955 | Compositions comprising b-arrestin 1 and methods of use thereof for therapeutic modulation of aldosterone levels in heart disease | Oct 4, 2011 | Issued |
Array
(
[id] => 8939495
[patent_doc_number] => 20130189292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions'
[patent_app_type] => utility
[patent_app_number] => 13/825037
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22801
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825037 | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions | Sep 21, 2011 | Abandoned |
Array
(
[id] => 7818520
[patent_doc_number] => 20120065140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Biomarkers for the Diagnosis of Autoimmune Disease'
[patent_app_type] => utility
[patent_app_number] => 13/231282
[patent_app_country] => US
[patent_app_date] => 2011-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12484
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065140.pdf
[firstpage_image] =>[orig_patent_app_number] => 13231282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/231282 | Biomarkers for the Diagnosis of Autoimmune Disease | Sep 12, 2011 | Abandoned |
Array
(
[id] => 9191036
[patent_doc_number] => 20130330352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/819393
[patent_app_country] => US
[patent_app_date] => 2011-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24493
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/819393 | TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS | Aug 31, 2011 | Abandoned |
Array
(
[id] => 10874448
[patent_doc_number] => 08899228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'Combination pressure therapy for treatment of chronic pain'
[patent_app_type] => utility
[patent_app_number] => 13/213982
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 12544
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13213982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/213982 | Combination pressure therapy for treatment of chronic pain | Aug 18, 2011 | Issued |
Array
(
[id] => 7776200
[patent_doc_number] => 20120039839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'Hypoxia Induced Mitogenic Factor'
[patent_app_type] => utility
[patent_app_number] => 13/211923
[patent_app_country] => US
[patent_app_date] => 2011-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7994
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039839.pdf
[firstpage_image] =>[orig_patent_app_number] => 13211923
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211923 | Method for treating pulmonary hypertension | Aug 16, 2011 | Issued |
Array
(
[id] => 7784890
[patent_doc_number] => 20120046446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'p16 MEDIATED REGULATION OF NMDA RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/209302
[patent_app_country] => US
[patent_app_date] => 2011-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15952
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046446.pdf
[firstpage_image] =>[orig_patent_app_number] => 13209302
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/209302 | p16 MEDIATED REGULATION OF NMDA RECEPTORS | Aug 11, 2011 | Abandoned |
Array
(
[id] => 8883569
[patent_doc_number] => 20130156753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/809789
[patent_app_country] => US
[patent_app_date] => 2011-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 12839
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809789
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809789 | THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF | Jul 30, 2011 | Abandoned |
Array
(
[id] => 10044377
[patent_doc_number] => 09084761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Use of interleukin-15 to treat cardiovascular diseases'
[patent_app_type] => utility
[patent_app_number] => 13/809154
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7002
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809154
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809154 | Use of interleukin-15 to treat cardiovascular diseases | Jul 7, 2011 | Issued |